139 related articles for article (PubMed ID: 18181041)
41. Plasmin system regulation in an ovalbumin-induced rat model of asthma.
Kucharewicz I; Mogielnicki A; Kasacka I; Buczko W; Bodzenta-Łukaszyk A
Int Arch Allergy Immunol; 2008; 147(3):190-6. PubMed ID: 18594148
[TBL] [Abstract][Full Text] [Related]
42. [The intracystic concentration of MCA in the fluid from large breast cysts].
Mezi S; Reale MG; Aloise G; Marigliani A; Marchei CG; Sallusti E; Mentuccia D; Del Nero A; Izzo P; Modesti M
G Chir; 1999 May; 20(5):246-51. PubMed ID: 10380368
[TBL] [Abstract][Full Text] [Related]
43. An analysis of the content and morphology of human breast microcysts.
Dixon JM; Scott WN; Miller WR
Eur J Surg Oncol; 1985 Jun; 11(2):151-4. PubMed ID: 3159597
[TBL] [Abstract][Full Text] [Related]
44. Expression of decorin in esophageal cancer in relation to the expression of three isoforms of transforming growth factor-beta (TGF-beta1, -beta2, and -beta3) and matrix metalloproteinase-2 activity.
Augoff K; Grabowski K; Rabczynski J; Kolondra A; Tabola R; Sikorski AF
Cancer Invest; 2009 May; 27(4):443-52. PubMed ID: 19212830
[TBL] [Abstract][Full Text] [Related]
45. Transforming growth factor beta isoforms (TGF-beta1, TGF-beta2, TGF-beta3) messenger RNA expression in laryngeal cancer.
Kapral M; Strzalka B; Kowalczyk M; Jurzak M; Mazurek U; Gierek T; Paluch J; Markowski J; Swiatkowska L; Weglarz L
Am J Otolaryngol; 2008; 29(4):233-7. PubMed ID: 18598833
[TBL] [Abstract][Full Text] [Related]
46. Gross cystic disease fluid protein (GCDFP-15) in the breast: past and present.
Sapino A; Cassoni P; Bussolati G
J Biol Regul Homeost Agents; 2000; 14(4):259-62. PubMed ID: 11215813
[No Abstract] [Full Text] [Related]
47. Transforming growth factor-beta regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment.
Bierie B; Stover DG; Abel TW; Chytil A; Gorska AE; Aakre M; Forrester E; Yang L; Wagner KU; Moses HL
Cancer Res; 2008 Mar; 68(6):1809-19. PubMed ID: 18339861
[TBL] [Abstract][Full Text] [Related]
48. Mitogenic peptides in breast cyst fluid: relationship with intracystic electrolyte ratios.
Lai LC; Ghatei MA; Takahashi K; Patel KV; Schrey MP; Ghilchik MW; Bloom SR; James VH
Int J Cancer; 1990 Dec; 46(6):1014-6. PubMed ID: 2249889
[TBL] [Abstract][Full Text] [Related]
49. Cytological and biochemical studies of breast cyst fluid.
Tsung JS; Wang TY; Wang SM; Yang PS
Breast; 2005 Feb; 14(1):37-41. PubMed ID: 15695079
[TBL] [Abstract][Full Text] [Related]
50. Bone tissue content of TGF-beta2 changes with time in human heterotopic ossification after total hip arthroplasty.
Suutre S; Toom A; Arend A; Selstam G
Growth Factors; 2009 Apr; 27(2):114-20. PubMed ID: 19180355
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of chemical parameters in breast cyst.
Venarucci D; Vallese A; Catalini P; Venarucci V
Panminerva Med; 1993 Jun; 35(2):108-12. PubMed ID: 8414623
[TBL] [Abstract][Full Text] [Related]
52. On the reaction of plasmin or plasmin-streptokinase complex with aprotinin or alpha 2-antiplasmin.
Wiman B
Thromb Res; 1980 Jan 1-15; 17(1-2):143-52. PubMed ID: 6154981
[No Abstract] [Full Text] [Related]
53. [Human gonadotrophic hormone (HCG) in benign breast cyst fluid. Association between type I and type II biological activities].
Ruibal A; Núñez MJ; Piqueras V; Rabadán F; Lapeña G; Schneider J; Tejerina A
Rev Esp Med Nucl; 2001 Apr; 20(2):156-8. PubMed ID: 11333827
[No Abstract] [Full Text] [Related]
54. Genistein inhibits aldose reductase activity and high glucose-induced TGF-beta2 expression in human lens epithelial cells.
Kim YS; Kim NH; Jung DH; Jang DS; Lee YM; Kim JM; Kim JS
Eur J Pharmacol; 2008 Oct; 594(1-3):18-25. PubMed ID: 18692043
[TBL] [Abstract][Full Text] [Related]
55. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
Moore LD; Isayeva T; Siegal GP; Ponnazhagan S
Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771
[TBL] [Abstract][Full Text] [Related]
56. Transforming growth factor-beta1 is the predominant isoform required for breast cancer cell outgrowth in bone.
Mourskaia AA; Dong Z; Ng S; Banville M; Zwaagstra JC; O'Connor-McCourt MD; Siegel PM
Oncogene; 2009 Feb; 28(7):1005-15. PubMed ID: 19079339
[TBL] [Abstract][Full Text] [Related]
57. Cation levels in human breast cyst fluid.
Bradlow HL; Skidmore FD; Schwartz MK; Fleisher M
Clin Oncol; 1981 Dec; 7(4):388-90. PubMed ID: 7318283
[No Abstract] [Full Text] [Related]
58. Quantification of prostate-specific antigen immunoreactivity in human breast cyst fluids.
Mannello F; Bocchiotti G; Bianchi G; Marcheggiani F; Gazzanelli G
Breast Cancer Res Treat; 1996; 38(3):247-52. PubMed ID: 8739076
[TBL] [Abstract][Full Text] [Related]
59. [The effect of plasmin and its complexes with alpha 2-macroglobulin and alpha 2-antiplasmin on the proliferative activity of human lymphocytes].
Musatov MI; Zhabin SG; Konenkov VI; Zorin NA
Biull Eksp Biol Med; 1994 Sep; 118(9):304-5. PubMed ID: 7529597
[No Abstract] [Full Text] [Related]
60. Abnormal transforming growth factor-beta expression in mesenchymal stem cells from patients with osteoarthritis.
Rollín R; Alvarez-Lafuente R; Marco F; García-Asenjo JA; Jover JA; Rodríguez L; López-Durán L; Fernández-Gutiérrez B
J Rheumatol; 2008 May; 35(5):904-6. PubMed ID: 18398939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
